Dossenheim, Germany

Blanka Leber

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Blanka Leber. Retrieved from https://idiyas.com/inventor/blanka-leber

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Blanka Leber: Innovator in Cancer Treatment

Introduction

Blanka Leber is a notable inventor based in Dossenheim, Germany. She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds.

Latest Patents

Blanka Leber holds a patent for "Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering." This invention relates to compounds of the formula (I), which are utilized in methods for treating cancer. The patent outlines the use of these compounds in the manufacture of pharmaceutical compositions aimed at treating cancer, as well as methods of treatment employing the specified compounds.

Career Highlights

Throughout her career, Blanka has worked with esteemed organizations such as the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts and the Deutsches Krebsforschungszentrum. Her work has focused on advancing cancer research and developing effective treatment options.

Collaborations

Blanka has collaborated with notable colleagues, including Alwin Kraemer and Mads Roennest, contributing to a dynamic research environment that fosters innovation in cancer treatment.

Conclusion

Blanka Leber's contributions to cancer treatment through her patented inventions and collaborative efforts highlight her role as a key innovator in the field. Her work continues to inspire advancements in medical research and pharmaceutical development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…